• Investment World
• eWorld
• Brand Line
• Mentor
• Life
• Canvas
• Praxis
• Urban Pulse
• Brand Quest
• The New Manager

Stocks

• Quotes
• SE Diary
• Scoreboard
• Open-End Mutual Fund

Cross Currency

• Rates
  
  

Shipping

• Ports
  
  

Archives

• Yesterday
• Datewise
• Resources
• In Focus
• In Depth

Group Sites

• The Hindu
• The Hindu ePaper
• Business Line
• Business Line ePaper
• Sportstar
• Frontline
• The Hindu eBooks
• The Hindu Images

Our Bureau

Bangalore June 8 The bioinformatics pie is worth $60 billion and big players such as TCS, Infosys, Wipro, Cognizant and HCL are scaling up for a share of this sector, according to speakers at the Bangalore Bio.

Bioinformatics is the tool for accelerated drug discovery. With intellectual property its main driver, companies are involved in clinical informatics, corporate IT, clinical development IT and scale IT.

According to Mr Sandeep Raju, Head of Delivery Operations, Life Sciences, Infosys, "The tremendous growth is reflected in package implementing, supporting and financing. Opportunities are enormous for software companies. One would in the near future see companies investing in building and owning IP in bioinformatics to fuel growth and revenues."

More Stories on : Bio-tech & Genetics | Software

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page

Stories in this Section
NTPC to pump Rs 6,000 cr into renewable energy

Copyright © 2007, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line